TACR1 and neoplasm: For the first time, we present the expression of TACR1 and TAC1 in rhabdoid tumors, the potent inhibitory effect of the NK1R antagonist aprepitant in this tumor entity and the analysis of apoptotic pathways of rhabdoid tumor cells upon treatment with aprepitant.